No insider purchase over the last 90 days. The latest was filed 08 Dec 2025.
XOMA Royalty Corp is a listed company. Filings by its managers are published through SEC (Form 4). The last twelve months, up to 18 October 2026, brought 41 filings signed by 11 insiders.
The flow runs one way only: 1 insider bought (1 purchase totalling €2.1M) and nobody sold on the market. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Hughes Owen filed the largest purchase, €2.1M, on 8 December 2025. The buyers include 1 chief executive.
The last purchase on record was published on 8 December 2025, which is 314 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4.
Compared with its exchange (5,458 companies, median 22 filings), a count of 41 filings is above the norm. Our records for XOMA Royalty Corp go back to 2016, with 26 purchases and 10 sales on the open market in total. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 52.1 m USD and net income at 31.7 m USD.
Elsewhere in the same market, our signals recently picked up insider purchases at GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
FY ended December 2025 · cache
25 of 98 declarations
XOMA Royalty Corp is a company focused on managing royalties related to pharmaceutical products. It specializes in acquiring and managing royalty rights on innovative drugs.
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 52.1 m USD | 31.7 m USD | 1.46 USD | 10-K |
| Dec 2024 | 28.5 m USD | -13.8 m USD | -1.65 USD | 10-K |
| Dec 2023 | 4.8 m USD | -40.8 m USD | -4.04 USD | 10-K |
| Dec 2022 | 6.0 m USD | -17.1 m USD | -1.98 USD | 10-K |
| Dec 2021 | 38.2 m USD | 15.8 m USD | 0.65 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.